Details for New Drug Application (NDA): 091608
NDA 091608 describes MEFENAMIC ACID, which is a drug marketed by Ajenat Pharms, Chartwell Rx, Lupin Ltd, Micro Labs, and Mpp Pharma, and is included in five NDAs. It is available from six suppliers. Additional details are available on the MEFENAMIC ACID profile page.
The generic ingredient in MEFENAMIC ACID is mefenamic acid. There is one drug master file entry for this compound. Six suppliers are listed for this compound. Additional details are available on the mefenamic acid profile page.
The generic ingredient in MEFENAMIC ACID is mefenamic acid. There is one drug master file entry for this compound. Six suppliers are listed for this compound. Additional details are available on the mefenamic acid profile page.
Summary for 091608
| Tradename: | MEFENAMIC ACID |
| Applicant: | Ajenat Pharms |
| Ingredient: | mefenamic acid |
| Patents: | 0 |
Pharmacology for NDA: 091608
| Mechanism of Action | Cyclooxygenase Inhibitors |
Medical Subject Heading (MeSH) Categories for 091608
Suppliers and Packaging for NDA: 091608
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| MEFENAMIC ACID | mefenamic acid | CAPSULE;ORAL | 091608 | ANDA | Misemer Pharmaceuticals, Inc | 0276-0509 | 0276-0509-30 | 30 CAPSULE in 1 BOTTLE (0276-0509-30) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 250MG | ||||
| Approval Date: | Jun 2, 2014 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
